Revenue: The sum of all revenue fields included for a company's operating activities.
Traws Pharma, Inc. (TRAW) had Revenue of $0.23M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$0.23M |
$-166.52M |
|
-- |
|
$0.23M |
|
$142.60M |
|
$-142.37M |
|
$-24.15M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-166.52M |
|
$-142.37M |
|
$-142.36M |
|
1.55M |
|
1.55M |
|
$-35.21 |
|
$-35.21 |
|
Balance Sheet Financials | |
$24.95M |
|
$0.01M |
|
$0.01M |
|
$24.96M |
|
$11.53M |
|
-- |
|
$45.06M |
|
$56.59M |
|
$-31.63M |
|
$-31.63M |
|
$-31.63M |
|
3.65M |
|
Cash Flow Statement Financials | |
$-29.79M |
|
$-3.65M |
|
$33.98M |
|
$20.82M |
|
$21.34M |
|
$0.52M |
|
$1.39M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-62997.35% |
|
-62997.35% |
|
-62992.04% |
|
-73682.74% |
|
-73682.74% |
|
$-29.79M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.13 |
|
2850.55 |
|
526.47% |
|
526.47% |
|
-667.11% |
|
526.47% |
|
$-8.66 |
|
$-19.19 |
|
$-19.19 |